Atlanta-based Oncology Analytics Launches Pharmacy Consulting Services

Since 2018 alone, the FDA has enabled over 140 new cancer indications, including 55 novel cancer drug entities. The growth of treatment options in oncology means that the stakes for patients, providers, and health plans have never been higher, yet managing the cancer drug information gap remains a significant challenge.

FREMONT, CA: Leading data analytics and technology-enabled services firm dedicated to helping health plans, providers, and patients with purpose-built solutions for oncology, Oncology Analytics, announced the launch of Pharmacy Consulting Services, designed to help health plans successfully navigate the world of anti-cancer drugs. New cancer treatments have been entering the market at an undaunting, accelerated pace. Since 2018 alone, the FDA has enabled over 140 new cancer indications, including 55 novel cancer drug entities. The growth of treatment options in oncology means that the stakes for patients, providers, and health plans have never been higher, yet managing the cancer drug information gap remains a significant challenge.

"For a health plan to successfully manage oncology drugs in today's innovation-driven climate, it requires insights from resources fully dedicated to oncology, typically beyond what may be internally available," said Laura Bobolts, PharmD, BCOP, senior vice president, clinical strategy and growth at Oncology Analytics. "Our Pharmacy Consulting Services ensure that a health plan's oncology drug policies provide coverage for the latest cancer therapies supported by evidence-based medicine and optimized for cost trend improvement."

Through the company's Pharmacy Consulting Services, health plans can access a team of board-certified oncology pharmacists and board-certified medical oncologists and hematologists to stay updated on the quickly changing cancer therapy landscape. With the help of this increased awareness, health plans can improve cancer care for their members and develop more cost-effective approaches to high-quality care.

The company's current customers for Pharmacy Consulting Services are receiving management and advisory services on their oncology drug policies. These health plans also have licensed Oncology Insights™, Oncology Analytics' real-world data analytics solution, which combines both clinical oncology and health plan data. This combination of technology and consulting services will continuously drive objective guidance to the health plans' oncology drug policies and identify new areas of opportunity and improvement.

"By combining data-driven analytic insights with a team of board-certified oncology pharmacy consultants, our health plan clients gain a trusted partner and advisor to help navigate the exploding complexity in anti-cancer drugs on both the medical benefit and pharmacy benefit formularies," said Rick Dean, CEO, Oncology Analytics. "We are thrilled that health plans partnering with Oncology Analytics for pharmacy consulting will receive access to our highly focused team of experts in oncology drug management."